Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety, tolerability, and immunogenicity of the V116 pneumococcal vaccine when given with an influenza vaccine in adults 50 and older; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Pneumonia
• Pneumonia

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• V116

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumonia, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2024-09-05